The new study, based on data from nearly 1,400 PAD patients who were treated with Shockwave Medical's IVL technology, was presented at VIVA22 in Las Vegas. 

The new guidance document was designed to help cardiologists and other clinicians deliver the best care possible when treating ASCVD patients who present with additional conditions that need to be considered. 

In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.

Nirmatrelvir-ritonavir, sold by Pfizer under the name Paxlovid, is commonly prescribed to treat COVID-19. When treating some heart patients, however, physicians may want to consider an alternative approach.

“This systemic failure is a global tragedy, as many premature deaths from CVD could be avoided,” one cardiologist said. 

FFR-guided PCI was associated with improved resource utilization and less radiation exposure, among other benefits, when compared to angiography-guided procedures.

The company plans to integrate the newly acquired microcatheters into its existing robotics platforms. 

Could wearables help AFib patients take fewer blood-thinning medications and reduce their risk of stroke? The team behind a new seven-year analysis hopes to find out.